Enfortumab vedotin (EV) plus pembrolizumab (P) in previously untreated locally advanced or metastatic urothelial cancer (la/mUC): An exploratory analysis in older patients (pts) and those with comorbidities from EV-302
  • Mar, N.
  • Gupta, S.
  • Powles, T. B.
  • Bedke, J.
  • Valderrama, B. Perez
  • 외 15명
Citations

WEB OF SCIENCE

0
Citations

SCOPUS

0
제목
Enfortumab vedotin (EV) plus pembrolizumab (P) in previously untreated locally advanced or metastatic urothelial cancer (la/mUC): An exploratory analysis in older patients (pts) and those with comorbidities from EV-302
저자
Mar, N.Gupta, S.Powles, T. B.Bedke, J.Valderrama, B. PerezKikuchi, E.Hoffman-censits, J.Drakaki, A.Yu, E. Y.Loriot, Y.Iyer, G.Vulsteke, C.Rey, J. P. MarotoSwami, U.Park, S. H.Moreno, B. HometMihm, M.Yu, C.Lu, J.Van Der Heijden, M. S.
DOI
10.1016/j.annonc.2025.08.3687
발행일
2025-09
유형
Meeting Abstract
저널명
Annals of Oncology
36